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Activation-induced cytidine deaminase (AID) is the mutator enzyme in adaptive immunity. AID
initiates the antibody diversiﬁcation processes in activated B cells by deaminating cytosine to
uracil in immunoglobulin genes. To some extent other genes are also targeted, which may lead to
genome instability and B cell malignancy. Thus, it is crucial to understand its targeting and
regulation mechanisms. AID is regulated at several levels including subcellular compartmenta-
lization. However, the complex nuclear distribution and trafﬁcking of AID has not been studied in
detail previously. In this work, we examined the subnuclear localization of AID and its interaction
partner CTNNBL1 and found that they associate with spliceosome-associated structures including
Cajal bodies and nuclear speckles. Moreover, protein kinase A (PKA), which activates AID by
phosphorylation at Ser38, is present together with AID in nuclear speckles. Importantly, we
demonstrate that AID physically associates with the major spliceosome subunits (small nuclear
ribonucleoproteins, snRNPs), as well as other essential splicing components, in addition to the
transcription machinery. Based on our ﬁndings and the literature, we suggest a transcription-
coupled splicing-associated model for AID targeting and activation.
& 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
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and MSH6 [42]. In the next steps, error-prone DNA polymerases
and factors involved in non-homologous end-joining (NHEJ) are
used to achieve SHM and CSR, respectively [49,59].
AID is a mutator protein and AID off-target activity is respon-
sible for many of the mutations and translocations involved in B
cell lymphomagenesis [30,36,46,48]. Thus, understanding its
detailed function, targeting and regulation is important. Tran-
scription is required for both SHM and CSR [12,41]. AID physically
interacts with the transcription apparatus, likely via the transcrip-
tion elongation factors, SPT5 [40] and PAF1 [56]. In addition, AID
interacts with the spliceosome-related factor CTNNBL1 (catenin-
beta-like protein 1) [7], the splicing regulator PTBP2 (polypyr-
imidine tract binding protein 2) [35], as well as several other
factors involved in splicing [56] and RNA processing [2]. However,
the role of these factors in Ig diversiﬁcation is still unclear.
AID is a nucleocytoplasmic shuttling protein that displays a
predominantly cytoplasmic localization [43]. The shuttling in and
out of the nucleus is driven by an NLS-dependent active nuclear
import mechanism [17,39] and exportin1-dependent nuclear
export [20], respectively. CTNNBL1 is a NLS-binding spliceosome-
associated protein that has been implicated in subcellular trafﬁck-
ing of AID [14], and recently we showed that CTNNBL1 and AID
colocalize in nucleoli [17].
In this study, the subnuclear localization of AID and CTNNBL1
and their association with splicing components were examined in
more detail. We found that AID and CTNNBL1 accumulate in
distinct nuclear domains enriched in spliceosome-associated
factors. Furthermore, we identiﬁed physical interactions between
AID and the major spliceosome subunits. Moreover, our results
indicate that activation of AID by PKA phosphorylation [1,6,37]
may be linked to the splicing machinery as well. Based on our
ﬁndings and the literature we suggest a model where a
transcription-coupled splicing complex may target AID to its
locus and regulate its function.Materials and methods
Plasmid constructs
Cloning of human AID cDNA (Image clone 4853069) into pECFP/
pEYFP-N1 and –C1 vectors (Clontech) and generation of con-
structs encoding YFP/CFP-tagged AID with C terminal truncations
were described previously [17]. The construct encoding the AID
splice variant, lacking exon 4, AIDΔ4-YFP (AID1-142-APV-YFP)
was made by site-directed mutagenesis of three codons (AID-
D143A-Y144P-F145V, 144P-145V generated an internal AgeI site)
in pAID-YFP followed by AgeI digestion and religation. Plasmid
encoding untagged AID was generated from the pAID-YFP con-
struct by excision of the YFP gene (AgeI-BsrG1 fragment), blunting
of ends by T4 DNA polymerase, ligation and reintroduction of AID
stop codon. AID-Cherry and AID1-186-Cherry were generated by
cloning AID or AID1-186 cDNA (from AID-YFP, or AID1-186-YFP)
into the pCherry-N1 vector as AgeI-NotI fragments. (pCherry-N1
and pCherry-C1 were made by replacing the YFP gene in the
pEYFP-N1 and -C1 vectors with the gene encoding Cherry).
pEGFP-CTNNBL1 [7] was a generous gift from Dr. Cristina Rada
and Dr. Michael Neuberger and the subcloning into pEYFP-C1 and
pECFP-C1 vectors was described previously [17]. pGFP-SMN waskindly provided by Dr. Jianhua Zhou. SMN cDNA was subcloned
into the pECFP-C1 and pCherry-C1 as BspE1-BamH1 fragments to
generate pCFP-SMN and pCherry-SMN. pGFP-U2AF65 was a
generous gift from Dr. Maria Carmo-Fonseca (Lisbon, Portugal)
to Dr. Marit Otterlei in our laboratory. Mutagenesis was carried
out using the Quick-Change™ mutagenesis kit (Stratagene) and
conﬁrmed by sequencing.Cell culture, transfection and confocal microscopy
HeLaS3, HEK-293T and U2OS were cultured in DMEM with 10%
fetal calf serum (FCS) and CH12F3 was maintained in RPMI,
supplied with 10% heat-inactivated FCS, 50 mM β-mercaptoetha-
nol, 1 mM Na-pyruvate. In addition, all cultures were supplied
with 0.03% L-glutamine, 0.1 mg/ml gentamicin or 1 PenStrep
and 2.3 mg/ml fungizone. Cells were transfected with FuGENE HD
or X-tremeGENE HP (Roche) according to the manufacturer0s
instructions and analyzed 24 h post transfection. When indicated,
cells were incubated with 10 ng/ml Leptomycin B (LeptB) (Sigma/
LC-labs) for 2–3 h if not speciﬁed otherwise. Permeabilization of
cells with digitonin was performed as previously described [17].
Cells were examined in a Zeiss LSM 510 laser scanning microscope
(1 mm thickness) with a Plan-Apochromat 63 /1.4 oil immersion
objective. CFP was excited at 458 nm and detected at 470–
500 nm, YFP was excited at 514 nm with detection between 530
and 600 nm (YFP was excited with 488 nm and detected at 505–
550 when cotransfected with Cherry), and Cherry was excited at
543 nm and detected above 615 nm.Cell ﬁxation and immunoﬂuorescence
Cajal bodies were identiﬁed by immunostaining of coilin. Cells
were ﬁxed in 2% paraformaldehyde (freshly made in PBS) for
10 min on ice and permeabilized with ice cold methanol (20 1C,
20 min). Cells where then rinsed in PBS, blocked in PBS containing
2% FCS and labeled with rabbit polyclonal anti-coilin antibody
(ab74739, Abcam) (1:300, 1 h at 37 1C) followed by Alexa Fluor
647 nm goat anti-rabbit antibody (#A-31633, Invitrogen).
For detection of nuclear speckles cells were ﬁxed and permea-
bilized in ice cold methanol (20 1C, 20 min). PBS with 0.3%
TritonX-100 and 5% BSA was used as blocking and staining buffer.
Cells were stained with mouse monoclonal anti-SC35 antibody
(#S4045, Sigma-Aldrich) (1:2000, overnight at 4 1C), followed by
Alexa ﬂuor 532 nm goat anti-mouse (#A-11002, Invitrogen) or
Alexa Fluor 647 nm goat anti-mouse (#A-21235, Invitrogen).
Double staining of coilin and SC35 (or AID) were performed on
methanol ﬁxed cells using the rabbit polyclonal anti-coilin and
mouse monoclonal anti-SC35 (or anti-AID #39-2500, Invitrogen,
1:200) primary antibodies at 4 1C overnight, followed by Alexa
Fluor 647 nm goat anti-rabbit and Alexa ﬂuor 532 nm goat anti-
mouse secondary antibodies.
Immunoﬂuorescence staining of PKA was performed by the
methanol ﬁxation protocol using PKA catalytic subunit-α rabbit
polyclonal antibody (#SC-903, Santa Cruz) (1:100 dilution, over-
night at 4 1C) and secondary antibody Alexa Fluor 647 nm goat
anti-rabbit. Cells were analyzed by confocal microscopy. Alexa
Fluor 532 nm was excited with 543 nm and detected between
560 nm and 615 nm while Alexa Fluor 647 nm was excited with
633 nm and detected above 650 nm.
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Western blot analysis
Cells expressing GFP- or YFP-tagged proteins were harvested 24 h
post transfection and rinsed in PBS. Cell pellets were suspended in
HEPES lysis buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 100 mM KCl, 0.5% NP-40) supplemented with 20%
glycerol, 1 CompleteTM protease inhibitor (Roche), 1 Phospha-
tase Inhibitor Cocktail 2 and 3 (Sigma), 200 U/ml OmniCleaveTM
Endonuclease (Epicentre) and 50 mg/ml RNase A (Sigma). The
suspensions were sonicated on ice (320 s, duty cycle 20% and
output 2.5) and cleared by centrifugation. Alternatively, cell pellet
was resuspended in 1 packed cell volume of buffer I (10 mM Tris–
HCl pH 8.0, 200 mM KCl, 1 mM EGTA, 1 mM DTT, 1.5 mMMgCl2, 1
CompleteTM protease inhibitor, 1 Phosphatase Inhibitor Cocktail
2/3, 200 U/ml OmniCleaveTM and 50 mg/ml RNase A) and lysed by
adding 1 packed cell volume of buffer II (buffer I supplemented
with 0.5% NP-40 and 40% glycerol). The mixture was rocked for 2 h
at 4 1C and cleared by centrifugation. Protein concentrations were
measured using the Bradford method (Bio-Rad).
GFP rabbit polyclonal antibodies (made in house) were cova-
lently cross-linked to protein A Dynabeads (Invitrogen) (0.1 mg
IgG/ml beads) using dimethyl pimelimidate dihydrochloride
(DMP) cross-linker according to the manufacturer0s instructions.
Freshly made cell extract (1 mg total protein) was incubated with
30 ml beads at 4 1C overnight. The beads were washed (31 ml)
with the HEPES lysis buffer supplemented with 10% glycerol or
with 10 mM Tris–HCl buffer containing 100 mM KCl. Proteins
were eluted from the beads in 30 μl 1 NuPAGE lithium dodecyl
sulfate (LDS) sample buffer (Invitrogen) containing 50 mM DTT
and heated at 70 1C for 15 min. Input lysates (70 mg) and IP
eluates (from 500 mg) were separated on NuPAGE Novex Bis-Tris
gels (Invitrogen), electroblotted onto Immobilon PVDF (Millipore)
membranes and subjected to Western blot analysis.
The primary antibodies used were (dilution/concentration in
brackets): rabbit polyclonal anti-GFP (made in-house or #ab290
Abcam) (0.5 mg/ml or 1:2000); rabbit polyclonal anti-CTNNBL1
(A302-663A, Bethyl) (1:2000); rabbit polyclonal anti-Coilin (B-7)
(ab74739, Abcam) (1:400); mouse monoclonal anti-AID (#39-
2500, Invitrogen) (1:1000); mouse monoclonal anti-AID L7E7
(#4975, Cell Signaling) (1:1000); mouse monoclonal anti-SMN1
2B1 (sc-32313, Santa Cruz) (1:200); mouse monoclonal anti-Sm B/
B0/N (H-9) (sc-374078, Santa Cruz) (1:400); rabbit polyclonal anti-
PKAα cat (C20) (sc-903, Santa Cruz) (1 mg/ml); mouse monoclonal
anti-CDC5L (BDB#612362)(1:5000); mouse monoclonal anti-
POLII (Rpb1-CTD) (#2629, Cell Signaling) (1:1000); rabbit poly-
clonal anti-SPT5 (H300) (sc-28678, Santa Cruz) (1:200); rabbit
polyclonal anti-Prp19 (ab27692, Abcam) (1 mg/ml); mouse mono-
clonal anti-U2AF65 (clone MC3, #U4758, Sigma)(0.1 mg/ml); rab-
bit polyclonal anti-β-tubulin (#2146S, Cell Signaling)(1:1000);
mouse monoclonal anti-SRSF1(sc-33652, Santa Cruz)(1:100); rab-
bit polyclonal anti-RBM5 (#SAB2101960, Sigma)(1:1000). HRP or
ﬂuorescent (LI-COR IRDye 680RD)-conjugated swine (or goat)
anti-rabbit or HRP-conjugated goat anti-mouse IgG were used
as secondary antibodies (1:5000 or 1:25,000, respectively). The
HRP membrane signals were developed using SuperSignal West
Femto (Pierce), visualized on a Kodak Image station 4000R, and
quantiﬁed using the Kodak Molecular Imaging NE4 software.
Fluorescent Western blot signals were visualized on a LI-COR
Odyssey infrared imaging instrument.Class switching assays
In vitro class switching was measured using ﬂow cytometry.
Approximately 2000 CH12F3 cells (10,000 cells/ml) were seeded in
ﬂat-bottomed 96-well plates in 200 ml growth medium. Cells were
stimulated with 2 μg/ml anti-CD40, and 10 ng/ml murine recombi-
nant IL-4 (Peprotech), and 1 ng/ml human recombinant TGF-β1
(Peprotech) for 4 days. The cells were then stained with LIVE/DEAD
violet viability stain (Invitrogen), blocked with Fc receptor antibody
(2.4G2) and normal mouse serum (Invitrogen), ﬁxed and permea-
bilized in CytoFix/CytopermTM, and washed in PermWashTM con-
taining saponin. Biotin-anti-mouse-IgA (eBioscience, clone 11-44-2)
was used for cytoplasmic staining of IgA and Streptavidin-Alexa
Flour 647 (Sigma) was used for detection. Cells were washed twice
with PermWashTM and suspended in 200 μl of CellFixTM before
analysis. Samples, unstained and single stained controls (including a
control with only streptavidin-AF647 for assessment of background
staining of endogenous biotin), were analyzed on a FACS Aria. Viable
CH12F3 cells were analyzed for YFP expression and IgA expression
using FlowJos version 7.6 for PC software. Reagents were from BD
Biosciences if not stated otherwise.Results
AID is localized in several subnuclear structures
To study subnuclear trafﬁcking of AID, we applied high resolution
confocal microscopy to live cells expressing AID with a ﬂuorescent
tag (Supplementary Fig. S1A) and inhibited nuclear export by the
speciﬁc exportin1 (CRM1) inhibitor, leptomycin B (LeptB). Shortly
after addition of LeptB, YFP-tagged AID (AID-YFP) entered the
nucleus and accumulated in nucleoli where it colocalized with the
nucleolar factor, ﬁbrillarin (Fib-Cherry) (Fig. 1A), as expected [17].
However, after prolonged LeptB treatment, AID-YFP was released
from nucleoli and accumulated in other nuclear foci (Fig. 1B). To
study this observation without adding the nuclear export inhi-
bitor, we used an alternative approach. Digitonin permeabilizes
the plasma membrane of cells and enables soluble factors to
diffuse out of the cytoplasm and nucleus, while proteins that are
structurally bound or are too large for diffusion through the
nuclear pores, are retained [58]. In digitonin-treated cells, AID-YFP
and the C-terminally truncated nuclear AID variant (YFP-AID1-
186) (Supplementary Fig. S1B) associated with nucleoli as well as
other subnuclear structures (Fig. 1C and D). In contrast, the
control proteins (Cherry- and YFP-tags) were completely washed
out by the digitonin treatment (Supplementary Fig. S1C). Thus,
these results demonstrate that AID associates with several differ-
ent subnuclear domains.
CTNNBL1 and AID localize to Cajal bodies
The AID-interacting factor CTNNBL1 is part of the Prp19/CDC5L
complex [15], which plays a central role during catalytic activation of
the spliceosome. Assembly and modiﬁcation of the major spliceo-
some subunits occur in distinct nuclear structures such as CBs [34].
This prompted us to investigate whether CTNNBL1 and AID may also
be localized to the CBs. In live cells we observed that GFP-tagged
CTNNBL1 often accumulated in several small nuclear foci in addition
to nucleoli (Fig. 2A). Moreover, CTNNBL1 and nuclear AID (AID1-186)
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Fig. 1 – AID accumulates in subnuclear foci. Representative confocal microscopy images of HeLa cells (live or digitonin-
permeabilized) expressing YFP-tagged AID together with Cherry-tagged ﬁbrillarin (Fib-Cherry) as marker of nucleoli. Images were
analyzed using the line proﬁle tool in the LSM 510 META (version 4.2 SP1) software package. Length of line is indicated on the
x-axis (lm). (A) Subnuclear localization of AID-YFP after 30 min LeptB treatment. (B) Subnuclear localization of AID-YFP 180 min
post LeptB. (C) Subnuclear accumulation of AID-YFP in digitonin-permeabilized cells (non LeptB treated). (D) Accumulation of the
nuclear AID variant (YFP-AID1-186) in nucleoli and other nuclear foci in digitonin-permeabilized cells. Representative images
of the cells before digitonin treatment are shown in Supplementary Fig. S1.
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ﬁxed cells (Fig. 2B). To identify CBs, we expressed CFP-tagged SMN
(survival of motor neuron) protein. The SMN complex accompanies
spliceosomal snRNP from cytoplasm to the CBs and constitutes a
major component of CBs [38]. Indeed, we found that CTNNBL1 and
SMN clearly colocalized in nuclear foci in live HeLa cells (Fig. 2C),
which strongly indicates that CTNNBL1 may be targeted to CBs. To
exclude the possibility that this was caused by overexpression of
SMN protein, we labeled the CBs by immunoﬂuorescence staining of
coilin, which is another major component of CBs. Using this
approach we demonstrated that CTNNBL1 colocalized with coilin
in CBs (Fig. 2D). Next we tested whether CTNNBL1 physically
interacted with CB proteins. To this end, GFP-SMN or GFP were
expressed in HEK cells and GFP-immunoprecipitation (GFP-IP) was
performed from whole cell extracts (WCEs). We used cell extracts
that were treated with nucleases to focus on direct protein:protein
interactions. In contrast to the GFP control, GFP-SMN clearly pulled
down endogenous CTNNBL1 (Fig. 2E). Moreover, applying the same
method on GFP-CTNNBL1-expressing cells, we veriﬁed that
CTNNBL1 also pulls down endogenous coilin (Fig. 2F). Note that
the β-tubulin control was neither pulled down by SMN norCTNNBL1. Taken together, these data show that CTNNBL1 localize
to CBs and interacts with major CB associated proteins.
Next, we examined AID with respect to CB localization. Simi-
larly to CTNNBL1, AID colocalized with SMN protein in distinct
nuclear foci in live HeLa cells, both at steady state and after
inhibition of nuclear export by LeptB (Fig. 3A). Moreover, physical
interaction between the SMN protein complex and AID was
conﬁrmed by GFP-IP experiments using HEK cells coexpressing
GFP-SMN and untagged AID (Fig. 3B). Localization of AID to CBs
was also demonstrated in AID-CFP-expressing cells that were
immunoﬂuorescence labeled with anti-coilin (Fig. 3C). Likewise,
physical association between AID and endogenous coilin and SMN
was veriﬁed by pull down in extracts from cells expressing either
the AID full length protein (YFP-AID) or the C-terminally trun-
cated nuclear AID variant (YFP-AID1-186) (Fig. 3D and E). Impor-
tantly, we also demonstrated that endogenous AID accumulates in
CBs by double immunoﬂuorescence labeling of AID and coilin in
an AID-expressing human B-cell line (Daudi) (Fig. 3F). To map
regions on AID required for its accumulation in CBs, AID-YFP
variants with C-terminal truncations or mutations were expressed
together with CFP-SMN in U2OS and HeLa cells. All C-terminally
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Fig. 2 – CTNNBL1 localizes to CBs and physically associates with the SMN complex and coilin. (A) Confocal microscopy images
showing subnuclear localization of GFP-CTNNBL1 in live U2OS cells expressing ﬁbrillarin (Fib-Cherry) as marker for nucleoli.
(B) Images showing the nuclei of live HeLa and ﬁxed (paraformaldehydeþmethanol) U2OS cells coexpressing tagged CTNNBL1,
AID1-186 and ﬁbrillarin. (C) Representative images of live HeLa cells coexpressing YFP-CTNNBL1 and CFP-SMN protein.
(D) Immunoﬂuorescence images of GFP-/YFP-CTNNBL1-expressing U2OS cells labeled with coilin antibody (CB marker). (E) Western
blot (WB) analysis showing pull down of endogenous CTNNBL1 by GFP-IP from GFP-SMN expressing HEK cells. (F) WB analysis
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logically occurring AID splice form lacking exon 4 (AIDΔ4) [57],
colocalized with SMN in live cells (Fig. 3G) and with both SMN
and coilin in ﬁxed cells (Fig. 3H).
Taken together, these data show that CTNNBL1 and AID localize
to CBs and physically interact with CB-associated factors in many
cell types including human B cells. Moreover, the C-terminal
region of AID is dispensable for its CB localization.
Localization of AID to CBs is independent of CTNNBL1
To further map the AID region essential for CB localization and
to study whether targeting of AID to CBs is dependent on
interaction with CTNNBL1 we used an extended panel of C-terminally truncated AID mutants (YFP-AID1-n). CTNNBL1 has
been implicated in subcellular trafﬁcking of AID [14] and we
have previously suggested that CTNNBL1 may target AID to
nucleoli [17]. In live cells expressing CFP-SMN protein as CB
marker, AID1-29 and AID1-39 were not targeted to Cajal bodies
although they were present in the nucleus. However, AID residues
1–84 were sufﬁcient for CB localization (Fig. 4A). Notably, the AID
mutants localized to CBs independently of nucleolar targeting
(Fig. 4A), and targeting of AID to CBs did not correlate with
efﬁciency of CTNNBL1 pull down (Fig. 4A and B). Neither did the
efﬁciency of CTNNBL1 pull down correlate with pull down of SMN
protein (Fig. 4B).
Next, we analyzed AID NLS single-point mutants. AID variants
showing disrupted nuclear and nucleolar targeting as well as
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 2 ( 2 0 1 4 ) 1 7 8 – 1 9 2 183CTNNBL1 binding [17], were still targeted to CBs when coex-
pressed with SMN (Fig. 4C). Moreover, they pulled down endo-
genous SMN protein to a relatively higher extent compared to
CTNNBL1 (Fig. 4D). In addition, we tested the ﬁrst characterized
CTNNBL1-binding deﬁcient AID mutant, with substitutions ofL1
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However, our ﬁndings suggest that CB targeting of AID may be
mediated by a mechanism involving the SMN complex.AID and CTNNBL1 localize to nuclear speckles and
associate with the spliceosomal snRNPs
Similar to CBs, nuclear speckles are subnuclear structures in the
interchromatin compartment. Nuclear speckles are the main sites
for maturation and storage of the splicing machinery [54]. To test
whether AID may be targeted to these sites, we coexpressed
cherry-tagged AID variants (AID-Cherry or AID1-186-Cherry) with
the GFP-tagged splicing factor U2AF65 (U2 auxiliary factor 65 kD
subunit), which accumulates in nuclear speckles [5,13]
(Supplementary Fig. S3). We observed clear colocalization of
AID-Cherry and GFP-U2AF65 in nuclear foci in LeptB and digitonin
treated cells (Fig. 5A), as well as in methanol ﬁxed cells expressing
the truncated nuclear form of AID (Fig. 5B). Supporting this
association, we demonstrated that U2AF65 efﬁciently pulled
down AID as well as endogenous CTNNBL1 (Fig. 5C). Likewise,
AID pulled down U2AF65 (Fig. 5D). Localization of AID and
CTNNBL1 to nuclear speckles was also demonstrated by immuno-
ﬂuorescence staining of the commonly used nuclear speckles
marker SC35 (serine/arginine rich splicing factor 2), (Fig. 5E and
F). Finally, double immunostaining of coilin and SC35 shows that
AID localizes to both CBs and nuclear speckles (Fig. 5G). This
suggests that AID may take part in the directional route from CBs
to nuclear speckles together with the splicing complex.
Both CBs and nuclear speckles are enriched in the major
spliceosomal building blocks, the snRNPs (U1, U2, U4, U5 and
U6) [52,53]. At the core of each snRNP, seven different Smith (Sm)
proteins (SmB, SmD1, SmD2, SmD3, SmE, SmF and SmG) form a
ring structure around the speciﬁc uracil-rich small nuclear RNA
(snRNA) molecules (U1-U6 RNA) [38]. GFP-IP from extracts from
HEK cells expressing either full length AID (YFP-AID) or the
nuclear major domain variant (YFP-AID1-186) [17], showed that
both forms of AID physically associate with the Sm proteins
(Fig. 6A). Similar to the AID:CTNNBL1 binding (Fig. 5B), interaction
between Sm proteins and AID required the complete major
domain of AID (AID1-186) (Fig. 6B). In addition, AID mutations
(K16E, R19E) that strongly impair CTNNBL1 binding and CSR [17],
also severely reduced the association between AID and Sm
proteins (Fig. 6C), as well as with the spliceosome activating
Prp19/CDC5L complex (Fig. 6D). This indicates that they are part
of the same complex (or share the same AID binding motif) and
that this complex is essential for its function.Fig. 3 – AID localizes to CBs and associates with the SMN complex
showing subnuclear localization of AID-CFP in live HeLa cells expre
show colocalization of AID and SMN protein in the nucleus of unt
showing GFP-IP from HEK cells expressing GFP-SMN (or GFP only)
nuclear foci. Immunoﬂuorescence images of LeptB treated AID-CFP
(D) AID associates physically with coilin. WB analysis showing pull
(WCE). HEK cells were transfected with either YFP-AID (mainly cyt
pulls down SMN protein. HEK cells were transfected with YFP-AID
from WCE. β-tubulin was used as loading control on the WBs. (F) C
Immunoﬂuorescence images of a human B cell line (Daudi) doubl
images of live U2OS cells coexpressing AID-YFP variants and CFP-S
labeled with anti-coilin (CB marker). The cells express AID-YFP vaTo summarize, we have shown that AID localizes to nuclear
speckles and associates with the major splicing machinery. More-
over, this association is dependent on the structural NLS motif on
the major domain of AID [17].
The catalytic subunit of PKA associates with AID in nuclear
speckles
Targeting of AID to deﬁned nuclear compartments may bring it in
contact with a set of speciﬁc binding partners and regulators. An
important AID regulator is the cAMP-dependent protein kinase A
(PKA) that phosphorylates AID at Ser38 and stimulates its
biological activity [1,43]. Interestingly, PKA is also involved in
regulation of transcription and splicing [26]. It is predominantly
localized in the cytoplasm, but a fraction of the catalytic α subunit
(PKA-Cα) enters the nucleus and is targeted to nuclear speckles,
likely by the Arg/Ser-rich splicing factor SFSR17A [22]. To inves-
tigate whether AID and PKA occur together in speciﬁc subnuclear
compartments, we performed PKA immunoﬂuorescence staining
of cells that express a nuclear AID variant. We found that nuclear
AID colocalized in several spots with endogenous PKA-Cα
(Fig. 7A). Interestingly, the spots overlapped with the nuclear
speckles marker SC35 (Fig. 7B). PKA was previously shown to
interact with AID in the cytoplasm [37]. Here we found that
cytoplasmic and nuclear AID variants pull down PKA with similar
efﬁciency (Fig. 7C), which demonstrate that also nuclear AID
interacts with PKA. As known, association of AID with the
transcription machinery is essential for its function [40]. There-
fore, we analyzed whether this physical connection was retained
in the truncated AID variant used in the localization study. Our
pull down experiments clearly demonstrated interaction between
RNA polymerase II (POLII) and full length AID, as well as for the
truncated variant (Fig. 7C).
Taken together our results show that AID and PKA-Cα associate
in the nucleus and colocalize in nuclear speckles, which may
suggest a spliceosome-associated regulation of AID activation.
AID interacts with the splicing machinery in switching B
cells
To get more insight into the association between AID and the
splicing machinery in Ig switching B-cells, we used the previously
generated CH12F3 mouse B-cell line that stably expresses AID-YFP
and the control cell line that expresses the YFP-tag [17] (Fig. 8A).
AID with a C-terminal tag (AID-GFP) is biologically active [39,43].
However, to ensure that the stably transfected cell lines were still
switch competent, we stimulated the cells with anti-CD40, IL4and coilin. (A) Representative confocal microscopy images
ssing Cherry-SMN protein as CB marker. Upper and lower panel
reated and LeptB treated cells, respectively. (B) WB analysis
and AID (without tag). (C) Colocalization of AID and coilin in
-expressing HEK cells labeled with coilin antibody (CB marker).
down of endogenous coilin by GFP-IP from whole cell extracts
osolic), YFP-AID1-186 (mainly nuclear) or YFP (control). (E) AID
1-186 (mainly nuclear) or YFP (control). GFP-IP was performed
olocalization of AID and coilin in nuclear foci in human B cells.
e labeled with AID and coilin antibodies. (G) Representative
MN protein. (H) Immunoﬂuorescence images of HeLa cells
riants together with CFP-SMN.
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Fig. 4 – Localization of AID to CBs is not dependent of CTNNBL1. (A) Representative confocal microscopy images of live HeLa cells
expressing C-terminally truncated AID variants (YFP-AID1-n) together with SMN protein (CFP-SMN). (B) Quantitative WB analysis
of CTNNBL1- and SMN-pull down by AID deletion mutants. Proteins were precipitated by GFP-IP fromWCE derived from HEK cells
expressing C-terminally truncated AID (YFP-AID1-n). YFP-AID1-n (bait), CTNNBL1 and SMN in the IP-fractions were quantiﬁed and
relative binding were calculated as intensity of CTNNBL1 and SMN, divided by intensity of YFP-AID1-n. The bars represent the mean
of 4-6 experiments and standard deviations are indicated on the bars. (C) AID mutants still colocalize with SMN in nuclear spots.
Live cell images of U2OS expressing AID NLS mutants together with SMN protein. (D) Quantitative WB analysis of CTNNBL1- and
SMN-pull down by AID NLS mutants. Proteins were pulled down by GFP-IP in cell extract derived from HEK cells expressing the
YFP-AID NLS mutants. Cells expressing the YFP tag only were used as negative control. Signals in the IP fraction were quantiﬁed
and relative binding calculated as the mean of 4 experiments.
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Fig. 5 – AID and CTNNBL1 localize to nuclear speckles. (A) AID colocalizes with the splice factor U2AF65 in nuclear spots. Representative
image of nuclei in permeabilized HeLa cells expressing AID-Cherry together with GFP-U2AF65. Cells were treated with LeptB followed by
digitonin directly before analysis in the confocal microscopy. (B) Image of a representative nucleus in methanol ﬁxed cells expressing the
C-terminally deleted nuclear form of AID (AID1-186-Cherry) together with GFP-U2AF65. (C) The splicing factor U2AF65 interacts with AID
and CTNNBL1. WB showing AID- and CTNNBL1-pull down by GFP-IP in extracts from transfected HEK cells coexpressing GFP-U2AF65
together with AID (untagged). (D) WB showing pull down of endogenous U2AF65 by GFP-IP in extracts from HEK cells expressing YFP-AID.
(E) AID colocalizes with the splice factor SC35. Immunoﬂuorescence images of HeLa cell (nucleus) labeled with anti-SC35 antibody
(speckles marker). The AID-YFP-expressing cells were permeabilized and ﬁxed with digitonin and methanol, respectively. (F) Nuclear AID
and CTNNBL1 both colocalize with SC35. Immunoﬂuorescence images of methanol ﬁxed HeLa cells, coexpressing nuclear AID variants and
CTNNBL1, labeled with anti-SC35. (E) AID may associate with CBs and nuclear speckles in the same cell. Immunoﬂuorescence image
showing the nucleus of a HeLa cell that express the truncated nuclear AID variant. Cells were methanol ﬁxed and labeled with anti-SC35
and anti-coilin to identify speckles and CBs, respectively.
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Fig. 6 – Association with snRNPs is dependent on the AID structural nuclear import motif. Mapping of association between the major
slicing components and AID by pull down and WB analysis. HEK cells were transfected with different YFP-tagged AID mutants (and
YFP control). GFP-IP was performed from WCEs. (A) Pull down of Sm proteins and CTNNBL1 by AID major domain (YFP-AID1-186)
and full length AID (YFP-AID1-198). (B) Pull down of Sm proteins by C-terminally truncated AID variants (YFP-AID1-n) (C) Pull
down of Sm proteins by AID NLS/CSR-deﬁcient mutants. (D) Pull down of the CDC5L splicing-associated factor by AID mutants.
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YFP-expressing control cells and the AID-YFP-expressing cells
switch to IgA with high efﬁciency after stimulation, 28% and
36%, respectively (Fig. 8A). We then performed GFP-IP experi-
ments and analyzed precipitated proteins by Western blots from
unstimulated () and CSR-stimulated (þ) cells. Notably, stimula-
tion was veriﬁed by detection of endogenous AID (25 kD) in the
input fractions for all experiments (Fig. 8B). Importantly, quanti-
tation of endogenous and tagged AID from Western blots (mean
from six blots) in stimulated cells showed that the total AID level
was only 70% higher in the AID-YFP cells than in the YFP control
cells (data not shown). This demonstrates that tagged AID is
expressed at biological relevant levels, which makes this a good
system to study physical association between AID and its inter-
acting partners.
We identiﬁed endogenous AID in the AID-YFP precipitated
protein complexes, indicating that we pulled down native AID
complexes. Except for AID, we found that the proteins analyzed
were generally similarly expressed in stimulated (þ) and unsti-
mulated () cells (input (þ)/input () ¼1) (Fig. 8B and C).
Likewise, association between AID and the transcription machin-
ery (POLII and SPT5), the activating kinase (PKA-Cα), the major
spliceosome snRNP components (Sm proteins), as well as thespliceosome-activating complex (Prp19/CDC5L/CTNNBL1) was not
signiﬁcantly inﬂuenced by CSR stimulation (Fig. 8B and C). Neither
was the Ser/Arg-rich splice factor 1 (SRSF1) (Supplementary Fig.
S4), which was reported to regulate Ig hypermutation in DT40
chicken B cells [24]. In contrast, we found that the association
between AID and U2AF65 was signiﬁcantly reduced in stimulated
cells (po0.05) (Fig. 8B and C). Interestingly, competition between
the constitutive auxiliary splice factor U2AF65 and other polypyr-
imidine tract-binding proteins is a common strategy to achieve
alternative splicing [28]. In fact, the RNA-binding motif protein
5 (RBM5) competes with U2AF65 and promote exon 4 skipping of
AID pre-mRNA [23]. However, we were not able to detect any
association between AID and RBM5 in our experiments
(Supplementary Fig. S4). Nevertheless, this ﬁndings indicate that
also components involved in alternative splicing may play a role to
regulate the biological activity of AID and that the link between
AID and the splicing machinery is central in switching B cells.Discussion
The nuclear space is highly organized, containing many dynamic
nuclear bodies that reﬂect the diverse functions and activities
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 2 ( 2 0 1 4 ) 1 7 8 – 1 9 2188[11]. Nuclear bodies are not restricted by membranes. Their
structural integrity is dependent on interactions between proteins
and/or nucleic acids, and exchange of factors between the various
bodies and nucleoplasm occurs continuously [27]. Likewise,
localization of AID to the various nuclear domains likely reﬂects
its dynamic association with components of these nuclearYFP-AID1-186 PKA-C -Ab 
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 structures. Previously, we demonstrated that AID and its interac-
tion partner CTNNBL1 are targeted to nucleoli [17]. Here we show
that they in addition localize to CBs and nuclear speckles, which
are the major spliceosome-associated compartments. Moreover,
we demonstrate that AID physically associates with the major
spliceosome subunits, the uracil-rich snRNPs (U1, U2, U4, U5 and
U6). Biogenesis of the snRNPs is a complex process. Newly
synthesized snRNAs are exported to the cytoplasm to undergo
various modiﬁcations and assembling into snRNPs. The snRNP
core complex consists of a heteroheptameric ring of Sm proteins
wrapped around the snRNA [45]. The mature cytoplasmic snRNPs
are subsequently transported into the nucleus, accompanied by
the SMN complex [33,51]. In the nucleus, the snRNPs may be
transferred from the SMN complex to coilin in CBs, or accumulate
in nucleoli to undergo further modiﬁcation and assembly, before
they enter nuclear speckles [21,50,53,61]. We have identiﬁed that
AID localizes to all these compartments and interacts with major
components (SMN, Coilin, Sm proteins) along this route. This
indicates that AID may trafﬁc together with the maturing
spliceosome.
The similar localization and interaction pattern observed for
AID and CTNNBL1 suggests that they are part of the same
complex. The crystal structure of CTNNBL1 was recently solved
and supports a direct interaction between AID and CTNNBL1 [19].
The structure reveals a negatively charged protein-binding groove
that ﬁts perfectly with the positively charged motif of AID that we
identiﬁed previously [17]. Although the precise function of
CTNNBL1 is unknown, it is part of the Prp19/CDC5L complex,
which plays a central role during activation of the spliceosome
[14,15]. Our results together with previous reports identifying
AID-interacting splice factors such as PTBP2 [35], SF3A, SF3B, Prp6
and Prp4 (V), strongly indicate a direct link between AID function
and the splicing machinery. Based on this we suggest a cotran-
scriptional splicing-coupled mechanism for AID targeting and
activation (Fig. 8D). Transcription and splicing is intimately linked
in vivo [31]. Recently, it was shown that the phosphorylated RNA
POLII C-terminal domain promotes splicing activation through
recruitment of the U2AF65 and the Prp19 complex [9,16]. More-
over, proteomic analysis of the human RNA POLII complex
identiﬁed that Ser-Arg-rich splice factors (SR proteins) and all
components of the 50 splice site-binding snRNP (U1), including
Sm proteins, associate with the active transcription complex [8].
AID could be linked to this RNA POLII spliceosomal complex both
through CTNNBL1 and other splicing- and transcription elonga-
tion factors, such as SPT5 [40] and PAF1 [56] (Fig. 8D). In switch
regions, the RNA transcripts are extensively paired with theFig. 7 – PKA and AID occur together in nuclear speckles. (A) AID
colocalizes with PKA-Cα in nuclear foci. Immunoﬂuorescence
image of methanol ﬁxed HeLa cells, expressing YFP-AID1-186
(major domain), labeled with anti-PKA-Cα. (B) AID colocalizes
with PKA-Cα in nuclear speckles. Immunoﬂuorescence image
of methanol ﬁxed U2OS cells, expressing CFP-AID1-186, labeled
with anti-PKA-Cα and anti-SC35. (C) WB analysis showing pull
down of PKA-Cα by AID. GFP-IP was performed in extracts
derived from transfected HEK cells expressing YFP-AID full
length (AID1-198) or the nuclear YFP-AID1-186 variant. Cells
expressing the YFP tag were used as negative control. Live HEK
cells expressing negative control (YFP) and the AID variants
are shown.
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bring AID directly in contact with its substrate DNA for targeted
activity. Growing evidence for the existence of a tight coupling
between DNA methylation status and regulation of pre-RNA
processing supports our model linking splicing and DNA editing
[4]. Moreover, we ﬁnd that CSR-defective mutants [17] fail to bind
splicing-related factors (this work). This splicing-associated AIDP
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IP (+/-) targeting model is also consistent with the high mutation rates
observed directly downstream of donor splice sites in both
variable and switch regions [29].
Interestingly, AID displayed reduced association with the aux-
iliary splice factor U2AF65 after stimulation. During splicing
U2AF65 binds the polypyrimidine tract element upstream of the
30 splice site and recruits the U2 snRNP to the pre-mRNA branchInput  GFP-IP 
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competition between the constitutive splice factor U2AF65 and
other polypyrimidine tract-binding proteins, such as the AID-
interacting factor PTBP2 [35], is a common strategy to mediate
alternative splicing [28]. Moreover, U2AF65 displacement is also
linked to RNA POLII stalling, which overlaps with the AID target
sites [40] and supports the transcription-coupled splicing linked
AID targeting model (Fig. 8D).
Phosphorylation of AID by PKA is required for both CSR and
SHM in vivo [6]. We found that AID colocalizes with PKA-Cα in
nuclear speckles and that nuclear AID also physically associates
with PKA. Indeed, this nuclear colocalization may be important to
regulate the biological activity of AID. Interestingly, a mechanism
for this activation of CSR was recently shown to be mediated by
ampliﬁcation of DNA breaks at switch regions through
phosphorylation-dependent interaction of AID with APE1 [55].
Nevertheless, based on the observation that semi-puriﬁed AID
requires treatment with RNase to remove inhibitory RNA and
become catalytically active [3], it is still tempting to speculate that
AID may be kept inactive in large RNA-containing snRNP com-
plexes until release mediated by PKA-dependent phosphorylation.
Based on our ﬁndings and the literature we suggest a model
where both AID targeting and activation is mediated by a
cotranscriptional splicing-associated mechanism that is tightly
linked to its substrate DNA.Acknowledgments
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